🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The Purpose of this trial is: * to determine complete response rate (CRR) ...
Status
Completed
Location
1st Dept. of Medicine, Cologne University Hospital
Start Date
2012-10
Trial ID
NCT01569204
The purpose of this study is to evaluate the safety and efficacy of pembrol...
Status
Completed
Location
St Joseph Heritage Healthcare-Oncology ( Site 0004)
Start Date
2021-10-07
Trial ID
NCT05008224
Patients with 1p/19q-codeleted anaplastic gliomas treated with RT + PCV are...
Status
Completed
Location
CHU d'Amiens- CHU nord
Start Date
2015-09-22
Trial ID
NCT02444000
Treatments Being Tested
This study aims to evaluate the efficacy brentuximab vedotin as consolidati...
Status
Completed
Location
CH Victor Dupouy
Start Date
2015-04
Trial ID
NCT02298283
1. To observe and compare the overall response rate (ORR) of baseline BEACO...
Status
Unknown
Location
Multiple Locations
Start Date
2016-06
Trial ID
NCT02800447
RATIONALE: Drugs used in chemotherapy, such as methotrexate, procarbazine, ...
Status
Completed
Location
Oregon Health & Science University Cancer Institute
Start Date
2000-01
Trial ID
NCT00074191
Treatments Being Tested
RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cell...
Status
Terminated
Location
Ireland Cancer Center at University Hospitals Case Medical Center, Case Comprehensive Cancer Center
Start Date
1997-07
Trial ID
NCT00003113
Treatments Being Tested
RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cell...
Status
Completed
Location
Indiana University Cancer Center
Start Date
2000-02
Trial ID
NCT00005796
The purpose of this study is to evaluate the safety and efficacy of lisocab...
Status
Recruiting
Location
University Of Colorado
Start Date
2025-11-06
Trial ID
NCT07015242
The choice of a preferred first-line treatment requires balancing the desir...
Status
Completed
Location
Fondazione IRCCS Istituto Nazionale di Tumori di Milano
Start Date
2000-03
Trial ID
NCT01251107